288 related articles for article (PubMed ID: 25281873)
1. Transcriptional activation of PRMT5 by NF-Y is required for cell growth and negatively regulated by the PKC/c-Fos signaling in prostate cancer cells.
Zhang HT; Zhang D; Zha ZG; Hu CD
Biochim Biophys Acta; 2014 Nov; 1839(11):1330-40. PubMed ID: 25281873
[TBL] [Abstract][Full Text] [Related]
2. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.
Deng X; Shao G; Zhang HT; Li C; Zhang D; Cheng L; Elzey BD; Pili R; Ratliff TL; Huang J; Hu CD
Oncogene; 2017 Mar; 36(9):1223-1231. PubMed ID: 27546619
[TBL] [Abstract][Full Text] [Related]
3. The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5.
Zhang HT; Zeng LF; He QY; Tao WA; Zha ZG; Hu CD
Biochim Biophys Acta; 2016 Feb; 1863(2):335-46. PubMed ID: 26658161
[TBL] [Abstract][Full Text] [Related]
4. Curcumin ameliorates PRMT5-MEP50 arginine methyltransferase expression by decreasing the Sp1 and NF-YA transcription factors in the A549 and MCF-7 cells.
Chatterjee B; Ghosh K; Suresh L; Kanade SR
Mol Cell Biochem; 2019 May; 455(1-2):73-90. PubMed ID: 30392062
[TBL] [Abstract][Full Text] [Related]
5. A Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells.
Shankar E; Song K; Corum SL; Bane KL; Wang H; Kao HY; Danielpour D
J Biol Chem; 2016 Mar; 291(11):5512-5526. PubMed ID: 26786102
[TBL] [Abstract][Full Text] [Related]
6. PRMT5-mediated methylation of YBX1 regulates NF-κB activity in colorectal cancer.
Hartley AV; Wang B; Mundade R; Jiang G; Sun M; Wei H; Sun S; Liu Y; Lu T
Sci Rep; 2020 Sep; 10(1):15934. PubMed ID: 32985589
[TBL] [Abstract][Full Text] [Related]
7. Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer.
Hartley AV; Wang B; Jiang G; Wei H; Sun M; Prabhu L; Martin M; Safa A; Sun S; Liu Y; Lu T
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456215
[TBL] [Abstract][Full Text] [Related]
8. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
[No Abstract] [Full Text] [Related]
9. PRMT5: a putative oncogene and therapeutic target in prostate cancer.
Beketova E; Owens JL; Asberry AM; Hu CD
Cancer Gene Ther; 2022 Mar; 29(3-4):264-276. PubMed ID: 33854218
[TBL] [Abstract][Full Text] [Related]
10. PRMT5-dependent transcriptional repression of c-Myc target genes promotes gastric cancer progression.
Liu M; Yao B; Gui T; Guo C; Wu X; Li J; Ma L; Deng Y; Xu P; Wang Y; Yang D; Li Q; Zeng X; Li X; Hu R; Ge J; Yu Z; Chen Y; Chen B; Ju J; Zhao Q
Theranostics; 2020; 10(10):4437-4452. PubMed ID: 32292506
[TBL] [Abstract][Full Text] [Related]
11. Protein arginine methyltransferase 5 regulates multiple signaling pathways to promote lung cancer cell proliferation.
Sheng X; Wang Z
BMC Cancer; 2016 Aug; 16():567. PubMed ID: 27480244
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
13. An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth.
Liu L; Yan H; Ruan M; Yang H; Wang L; Lei B; Sun X; Chang C; Huang G; Xie W
Cancer Sci; 2021 Aug; 112(8):3083-3098. PubMed ID: 34033176
[TBL] [Abstract][Full Text] [Related]
14. Methylosome Protein 50 and PKCδ/p38δ Protein Signaling Control Keratinocyte Proliferation via Opposing Effects on p21Cip1 Gene Expression.
Saha K; Eckert RL
J Biol Chem; 2015 May; 290(21):13521-30. PubMed ID: 25851901
[TBL] [Abstract][Full Text] [Related]
15. Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling.
Chung J; Karkhanis V; Baiocchi RA; Sif S
J Biol Chem; 2019 May; 294(19):7692-7710. PubMed ID: 30885941
[TBL] [Abstract][Full Text] [Related]
16. ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor.
Mounir Z; Korn JM; Westerling T; Lin F; Kirby CA; Schirle M; McAllister G; Hoffman G; Ramadan N; Hartung A; Feng Y; Kipp DR; Quinn C; Fodor M; Baird J; Schoumacher M; Meyer R; Deeds J; Buchwalter G; Stams T; Keen N; Sellers WR; Brown M; Pagliarini RA
Elife; 2016 May; 5():. PubMed ID: 27183006
[TBL] [Abstract][Full Text] [Related]
17. Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma.
Karkhanis V; Alinari L; Ozer HG; Chung J; Zhang X; Sif S; Baiocchi RA
J Biol Chem; 2020 Jan; 295(5):1165-1180. PubMed ID: 31822509
[TBL] [Abstract][Full Text] [Related]
18. Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin-dependent kinases and the phosphoinositide 3-kinase/AKT signaling cascade.
Wei TY; Juan CC; Hisa JY; Su LJ; Lee YC; Chou HY; Chen JM; Wu YC; Chiu SC; Hsu CP; Liu KL; Yu CT
Cancer Sci; 2012 Sep; 103(9):1640-50. PubMed ID: 22726390
[TBL] [Abstract][Full Text] [Related]
19. PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cells.
Ge L; Wang H; Xu X; Zhou Z; He J; Peng W; Du F; Zhang Y; Gong A; Xu M
J Cell Mol Med; 2020 Jan; 24(2):1969-1979. PubMed ID: 31851779
[TBL] [Abstract][Full Text] [Related]
20. Targeting PRMT5/Akt signalling axis prevents human lung cancer cell growth.
Zhang S; Ma Y; Hu X; Zheng Y; Chen X
J Cell Mol Med; 2019 Feb; 23(2):1333-1342. PubMed ID: 30461193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]